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ABSTRACT 
This study evaluates dynamic conformal arc (DCA) therapy as an alternative to volumetric 
modulated arc therapy (VMAT) for stereotactic body radiation therapy (SBRT) of lung cancer. 
The rationale for DCA is lower geometric complexity and hence reduced risk for interplay 
errors induced by respiratory motion. Forward planned DCA and inverse planned DCA based 
on segment-weight optimization were compared to VMAT for single arc treatments of three 
lung patients. Analysis of dose-volume histograms and clinical goal fulfillment revealed that 
DCA can generate satisfactory and near equivalent dosimetric quality to VMAT, except for 
complex tumor geometries. Segment-weight optimized DCA provided spatial dose 
distributions qualitatively similar to those for VMAT. Our results show that DCA, and 
particularly segment-weight optimized DCA, is an attractive alternative to VMAT for lung SBRT 
treatments, where errors from intrafraction motion cannot be expected to average out over 
the course of the treatment. 
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1. INTRODUCTION 
Stereotactic body radiation therapy (SBRT) is standard of care for inoperable non-small cell lung cancer 
(NSCLC) (Ettinger, et al. 2017). In the United States, SBRT for NSCLC is delivered in 1-5 fractions and with 
up to 10 fractions internationally, both using biological effective doses in excess of 100 Gy (Videtic, et al. 
2017). Radiation dose delivery to moving targets, such as lung tumors, has been a fundamental challenge 
in radiation oncology. Traditional approaches to account for motion have entailed expansion of the gross 
or clinical target volume to include the entire range of motion; defined as the internal target volume (ITV) 
(Chavaudra and Bridier, 2001). Several other devices and strategies have been developed to manage and 
minimize the effects of respiratory motion, including compression and breath hold devices (Keall, et al. 
2006). A recent advance is the development of robust radiotherapy plans, where the uncertainty in the 
target location is parameterized in the optimization (Unkelbach, et al. 2018). 
 
Currently, the most common approach for lung SBRT is treatment to an ITV using volumetric modulated 
arc therapy (VMAT), where dose is delivered during an arc with simultaneous dynamic motion of the multi-
leaf collimator (MLC) leaves (Palma, et al. 2010). Current optimization methods do not constrain leaf 
motion to prevent occlusion of the target. This form of treatment delivery is susceptible to dosimetric 
errors from unexpected interplay between organ motion and MLC leaf motion—a phenomenon termed 
the interplay effect (Jiang, et al. 2003 and Seco, et al. 2007). The interplay effect can create significant 
dosimetric deviations greater than 20%; however, the effect averages out over traditionally fractionated 
(>25) courses of intensity-modulated radiation therapy (IMRT) (Bortfeld, et al. 2002). With 
hypofractionated courses, studies have shown the necessity of using multiple arcs to yield the averaging 
benefit to SBRT lung with VMAT (Court, et al. 2010 and Ong, et al. 2011). 
 
Eliminating concern of the interplay effect, forward-planned, dynamic conformal arc (DCA) treatments are 
known to be efficient and clinically effective (Ross, et al. 2011 and Ku, et al. 2016). The contrast between 
DCA and VMAT is illustrated in Figure 1. Note that the VMAT plan in this figure has some MLC leaves 
occluding the target whereas the leaves are conformed to the shape of the target for the DCA plan. 
Dosimetric accuracy has also been demonstrated to decrease with increased modulation complexity and 
average leaf travel (Masi, et al 2013). With the high degree of precision required for hypofractionated 
treatments, it is important to ensure radiotherapy plans are adequately but not overly complex. 
 
The current study reviews the DCA planning method within the RayStation (RaySearch Laboratories, 
Stockholm, Sweden) treatment planning system and compares DCA to VMAT plans, highlighting the 
appropriate selection of each technique. We also evaluate RayStation’s capability to generate segment-
weight optimized dynamic conformal arc (SWO-DCA) plans, where a non-uniform number of monitor units 
(MUs) as a function of the gantry angle is determined by inverse planning techniques. This type of 
optimization is, similar to optimization for VMAT, driven towards fulfilment of a set of user-defined 
objective functions. However, only the number of MUs per segment are varied during the optimization, 
the MLC leaves are kept unchanged at their conformed positions relative to the target volume.  
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(a) DCA      (b) VMAT 
Figure 1. Typical segment shapes for DCA and VMAT treating a target volume indicated by the red contour. 
MLC leaves are shown in brown and jaws shown in blue. 
 
2. METHODS  
Treatment plans were generated for three anonymized patients (patients 1-3) using RayStation 7.0. 
Treatment planning was performed with the average image derived from all phases of a four-dimensional 
computed tomography (4DCT) dataset. An ITV was created using the maximum intensity projection 4DCT. 
Three plans were developed per patient: a standard DCA plan, an SWO-DCA plan, and a VMAT plan. All 
using a single coplanar arc with a 6 MV energy beam from a TrueBeam linear accelerator (Varian Medical 
Systems, Palo Alto, CA). Arc lengths of 255, 210, and 240 degrees were used for patients 1, 2, and 3, 
respectively. The fractionation schedule used was 60 Gy in 8 fractions. The DCA plan of each patient was 
created by conforming the MLC to the ITV with a margin of 0.5 cm and scaling the number of MUs to 
achieve D95% to the prescription level. The SWO-DCA and VMAT plans were generated by optimization 
with respect to objectives defined in accordance with patient-specific clinical goals, as summarized in 
Tables 2-4. The standard DCA plan was used as initial point for the SWO-DCA optimizations. 
 
Treatment plans were evaluated with respect to level of clinical goal fulfilment and dose-volume 
histograms (DVHs). Treatment plan complexity was assessed in term of the modulation complexity score 
(MCS), the score being introduced by McNiven, et al. (2010) for static-field IMRT and later adapted to 
VMAT by Masi, et al. (2013). The MCS score depends on the leaf position variability between adjacent 
active leaves and the aperture area variability. The score is dimensionless and ranges from 0 to 1, with a 
value of 1 corresponding to the lowest possible complexity (a rectangular field). The set of active leaf pairs 
used for the MCS evaluation was defined as the leaf pairs with a tip gap inside the jaw opening that is 
greater than the minimum dynamic tip for at least one control point. Plan complexity was also assessed in 
terms of total leaf travel, averaged over the active leaf pairs, and total MU variability. 
 
3. RESULTS  
The dose distributions of the treatment plans are illustrated with DVHs in Figure 2 and 3D dose 
distributions for a transversal slice in Figures 3-5. The contours for regions of interest (ROIs) in these figures 
are indicated in colors in accordance with Figure 2. The examined plan complexity metrics are summarized 
in Table 1 and the level of clinical goal fulfilment per patient case summarized in Tables 2-4.  
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In the first patient case, all clinical goals were achieved with the three treatment techniques (Table 2). In 
the second patient case, clinical goals were achieved, with exception of the spinal cord with the standard 
DCA plan (Table 3). The third case had the most complex geometry, with a large centrally located target 
proximal the spinal cord. In this case, neither DCA nor SWO-DCA plans could be created to fulfill all clinical 
goals (Table 4). The standard DCA plan failed on sparing of the spinal cord and trachea, whereas the SWO-
DCA plan failed the spinal cord. In addition to improved sparing of the trachea, SWO-DCA also led to 
improved sparing of the esophagus compared to standard DCA, as evident in Figure 2(c). The VMAT plan 
fulfilled all goals for patient 3 (Table 4).  
 
Figures 3-5 show standard DCA plans produce relatively symmetrical dose distributions. The SWO-DCA and 
VMAT plans, in contrast, yielded heavily weighted anterior and posterior dose delivery for all three cases. 
The VMAT plans generally exhibited a higher level of complexity than standard DCA and SWO-DCA plans 
according to evaluated complexity metrics. The exception to this general pattern was the MCS value for 
patient 2, which was lower for SWO-DCA than VMAT. The lower MCS value (higher complexity) of the 
SWO-DCA plan was due to a higher level of aperture area variability, which for this patient was caused by 
irregular target geometry. The VMAT plan is, arguably, the more complex plan having a factor 2.8 higher 
average leaf travel per degree and a factor 2.3 higher MU variability per degree. 
 
 
(a) Patient 1   (b) Patient 2   (c) Patient 3 
Figure 2. DVHs for the three patient cases. The standard DCA plan is indicated by solid lines, the SWO-DCA 
plan indicated by dashed lines, and the VMAT plan indicated by dotted lines. 
 
Table 1. Summary of obtained plan complexity metrics per patient and plan generation technique.  
MCS = modulation complexity score. LT = average leaf travel. ∆MU = MU variation per degree. 
Patient Metric DCA SWO-DCA VMAT 
P1 MCS (-) 0.62 0.63 0.60 
LT (cm) 2.5 2.5 4.6 
∆MU (MU/°) 0.0 25.5 34.9 
P2 MCS (-) 0.45 0.43 0.45 
LT (cm) 5.1 5.1 14.6 
∆MU (MU/°) 0.0 60.9 138.0 
P3 
 
MCS (-) 0.51 0.50 0.37 
LT (cm) 2.9 2.9 21.0 
∆MU (MU/°) 0.0 103.3 129.1 
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(a) DCA    (b) SWO-DCA   (c) VMAT 
Figure 3. Dose distributions for patient 1 for a transversal cut through the isocenter, overlaid on the 
planning CT. Contours for ROIs are indicated by solid lines according to the color scheme of Figure 2(a). 
The color table is in percent of the prescription dose (60 Gy). 
 
 
(a) DCA    (b) SWO-DCA   (c) VMAT 
Figure 4. Dose distributions for patient 2 for a transversal cut through the isocenter, overlaid on the 
planning CT. Contours for ROIs are indicated by solid lines according to the color scheme of Figure 2(b). 
The color table is in percent of the prescription dose (60 Gy). 
 
 
(a) DCA    (b) SWO-DCA   (c) VMAT 
Figure 5. Dose distributions for patient 3 for a transversal cut through the isocenter, overlaid on the 
planning CT. Contours for ROIs are indicated by solid lines according to the color scheme of Figure 3(c). 
The color table is in percent of the prescription dose (60 Gy). 
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Table 2. Fulfilment of clinical goals on maximum dose at volume for Patient 1. Satisfied goals are 
indicated in green and violated goals indicated in red.  
ROI Maximum dose at volume  Resulting dose (Gy) at volume 
DCA SWO-DCA VMAT 
Spinal cord 13.5 Gy at 0.5 cm3 7.93 6.96 6.16 
 22.5 Gy at 0.25 cm3 8.07 7.19 6.43 
 30.0 Gy at 0 cm3 9.01 8.19 7.40 
Lung (Right & Left) 12.5 Gy at 1500 cm3 2.71 1.78 1.59 
 13.5 Gy at 1000 cm3 8.74 7.40 6.36 
Heart 32.0 Gy at 15 cm3 8.87 5.45 4.90 
 63.0 Gy at 0 cm3 12.2 8.39 7.17 
Trachea 18.0 Gy at 4 cm3 1.25 0.87 0.80 
 63.0 Gy at 0 cm3 12.0 6.89 6.48 
 
Table 3. Fulfilment of clinical goals on maximum dose at volume for Patient 2. Satisfied goals are indicated 
in green and violated goals indicated in red.  
ROI Maximum dose at volume  Resulting dose (Gy) at volume 
DCA SWO-DCA VMAT 
Spinal cord 13.5 Gy at 0.5 cm3 16.7 11.7 12.6 
 22.5 Gy at 0.25 cm3 17.0 12.4 13.1 
 30.0 Gy at 0 cm3 18.6 13.3 13.9 
Lung (Right & Left) 12.5 Gy at 1500 cm3 5.53 4.16 5.31 
 13.5 Gy at 1000 cm3 9.07 7.56 9.84 
Heart 32.0 Gy at 15 cm3 30.0 28.5 29.0 
 63.0 Gy at 0 cm3 61.3 61.3 62.3 
Esophagus 27.5 Gy at 5 cm3  20.8 14.4 19.4 
 63.0 Gy at 0 cm3 30.0 21.9 28.7 
 
Table 4. Fulfilment of clinical goals on maximum dose at volume for Patient 3. Satisfied goals are indicated 
in green and violated goals indicated in red.  
ROI Maximum dose at volume  Resulting dose (Gy) at volume 
DCA SWO-DCA VMAT 
Spinal cord 13.5 Gy at 0.5 cm3 25.0 17.2 12.7 
 22.5 Gy at 0.25 cm3 25.9 18.8 14.6 
 30.0 Gy at 0 cm3 30.0 29.8 22.5 
Lung (Right & Left) 12.5 Gy at 1500 cm3 11.3 0.89 0.96 
 13.5 Gy at 1000 cm3 44.3 2.31 2.46 
Heart 32.0 Gy at 15 cm3 0.65 0.61 0.65 
 63.0 Gy at 0 cm3 0.87 0.78 0.84 
Trachea 18.0 Gy at 4 cm3 25.8 17.9 16.5 
 63.0 Gy at 0 cm3 40.2 40.3 38.6 
Esophagus 27.5 Gy at 5 cm3  24.6 12.5 11.5 
 63.0 Gy at 0 cm3 44.1 36.0 40.0 
Great vessels 47.0 Gy at 10 cm3 17.2 19.5 25.2 
 63.0 Gy at 0 cm3 52.7 59.0 59.9 
 
7 
 
4. DISCUSSION 
Our results demonstrate DCA plans can achieve satisfactory and nearly equivalent plans to VMAT under 
favorable conditions. Based on the cases examined in this study, situations when DCA can provide dose 
distributions of comparable quality to VMAT are lesions that are not proximal to dose-limiting OARs. We 
observed that complex cases with proximal OARs are better served with advanced treatment techniques 
such as VMAT. 
 
It was observed that segment weight optimization can considerably improve DCA plan quality with 
negligible change in plan complexity. Dose distributions of the SWO-DCA plans were also observed to be 
similar to VMAT plans. Thus, we have demonstrated that DCA, and particularly SWO-DCA, is a simple 
technique to create single arc lung SBRT plans of comparable quality with VMAT, while eliminating 
concerns of interplay and reducing complexity. 
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